2004年NCI-TARGET /Treatment取得美国「抗癌制剂(Anti-tumor Composition)医学专利。并分别从癌细胞试验及抗癌疗效之动物模式证明具抗癌功效且无毒性(LD50=4000mg)，可有效用于临床食用。
基于1个网页-相关网页
They were surprised to find that the microenvironment around the tumor determines both the tumor's shape and its composition.
他们惊奇的发现肿瘤周围的微环境决定了肿瘤的形态和肿瘤合成物。
The survival time and the tumor inhibition rate of Astragalus composition F3 new preparation were studied.
研究黄芪成分F_3新制剂对荷瘤小鼠生存期及实体瘤生长抑制的影响。
The present invention describes the use of trifunctional bispecific antibodies for the preparation of a pharmaceutical composition for the prophylaxis and treatment of tumor diseases.
本发明描述了三官能双特异性抗体用于制备用来预防和治疗肿瘤疾病的药物组合物的应用。
应用推荐